BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29105549)

  • 1. Value of extranodal extension detected by computed tomography for predicting clinical response after chemoradiotherapy in head and neck squamous cell cancer.
    Moon H; Choi YJ; Lee YS; Lee SW; Kim SB; Roh JL; Choi SH; Nam SY; Kim SY
    Acta Otolaryngol; 2018 Apr; 138(4):392-399. PubMed ID: 29105549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative Contrast-Enhanced CT Versus ¹⁸F-FDG PET/CT Evaluation and the Prognostic Value of Extranodal Extension for Surgical Patients with Head and Neck Squamous Cell Carcinoma.
    Lee JR; Choi YJ; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1020-7. PubMed ID: 26122372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of Radiological Extranodal Extension Detected by Computed Tomography for Predicting Outcomes in Patients With Locally Advanced Head and Neck Squamous Cell Cancer Treated With Radical Concurrent Chemoradiotherapy.
    Mahajan A; Chand A; Agarwal U; Patil V; Vaish R; Noronha V; Joshi A; Kapoor A; Sable N; Ahuja A; Shukla S; Menon N; Agarwal JP; Laskar SG; D' Cruz A; Chaturvedi P; Chaukar D; Pai PS; Pantvaidya G; Thiagarajan S; Rane S; Prabhash K
    Front Oncol; 2022; 12():814895. PubMed ID: 35719994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of tumor response to chemoradiotherapy and predicting prognosis in patients with head and neck squamous cell carcinoma by PERCIST.
    Katsuura T; Kitajima K; Fujiwara M; Terada T; Uwa N; Noguchi K; Doi H; Tamaki Y; Yoshida R; Tsuchitani T; Fujita M; Yamakado K
    Ann Nucl Med; 2018 Aug; 32(7):453-462. PubMed ID: 29858797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic effect of radiological extranodal extension in HPV-positive oropharyngeal squamous cell carcinomas: a retrospective cohort analysis.
    Meulemans J; Werpin L; Hermans R; Laenen A; Nuyts S; Clement PM; Delaere P; Van Lierde C; Vander Poorten V
    Eur Arch Otorhinolaryngol; 2024 Mar; 281(3):1541-1558. PubMed ID: 38170212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
    Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
    Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and prognostic significance of extranodal extension in isolated nodal recurrence of oral squamous cell carcinoma.
    Chang CW; Wang C; Lu CJ; Wang CW; Wu CT; Wang CP; Yang TL; Lou PJ; Ko JY; Chang YL; Chen TC
    Radiother Oncol; 2022 Feb; 167():81-88. PubMed ID: 34902369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of PET/CT with (18)F-fluoroazomycin arabinoside for patients with head and neck squamous cell carcinomas receiving chemoradiotherapy.
    Saga T; Inubushi M; Koizumi M; Yoshikawa K; Zhang MR; Obata T; Tanimoto K; Harada R; Uno T; Fujibayashi Y
    Ann Nucl Med; 2016 Apr; 30(3):217-24. PubMed ID: 26662072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of treatment and high-risk features in resectable locally advanced Head and Neck squamous cell carcinoma with special reference to extracapsular extension of nodal disease.
    Krstevska V
    J BUON; 2015; 20(4):943-53. PubMed ID: 26416042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy Response Assessment and Patient Outcomes in Head and Neck Squamous Cell Carcinoma: FDG PET Hopkins Criteria Versus Residual Neck Node Size and Morphologic Features.
    Wray R; Sheikhbahaei S; Marcus C; Zan E; Ferraro R; Rahmim A; Subramaniam RM
    AJR Am J Roentgenol; 2016 Sep; 207(3):641-7. PubMed ID: 27341273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Image guided volumetric response during chemoradiotherapy for head and neck squamous cell carcinoma as a predictor of disease outcomes.
    Davuluri R; Krase JM; Cui H; Goyal UD; Cheung MK; Hsu CC; Yi SK
    Am J Otolaryngol; 2016; 37(4):304-10. PubMed ID: 27105977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy and its added value to Human Papillomavirus status.
    Ou D; Blanchard P; Rosellini S; Levy A; Nguyen F; Leijenaar RTH; Garberis I; Gorphe P; Bidault F; Ferté C; Robert C; Casiraghi O; Scoazec JY; Lambin P; Temam S; Deutsch E; Tao Y
    Oral Oncol; 2017 Aug; 71():150-155. PubMed ID: 28688683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of Computerized Tomography density patterns of lymph nodes with treatment results and outcome in head and neck cancer patients treated by 2 different chemoradiotherapy schedules.
    Jaju S; Gupta SK; Pandey S; Singh V
    J Cancer Res Ther; 2014; 10(2):284-93. PubMed ID: 25022379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of radiographic extracapsular extension in locally advanced head and neck squamous cell cancers.
    Liu JT; Kann BH; De B; Buckstein M; Bakst RL; Genden EM; Posner MR; Som PM; Gupta V
    Oral Oncol; 2016 Jan; 52():52-7. PubMed ID: 26728104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-center retrospective study of the prognosis and treatment outcomes of Japanese oral squamous cell carcinoma patients with single lymph node metastasis and extra nodal extension.
    Hasegawa T; Yanamoto S; Otsuru M; Kakei Y; Okura M; Yamakawa N; Yamada SI; Ota Y; Umeda M; Kirita T; Kurita H; Ueda M; Komori T;
    J Surg Oncol; 2018 Jun; 117(8):1736-1743. PubMed ID: 29714825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Node-positive cutaneous squamous cell carcinoma of the head and neck: Survival, high-risk features, and adjuvant chemoradiotherapy outcomes.
    Amoils M; Lee CS; Sunwoo J; Aasi SZ; Hara W; Kim J; Sirjani D; Colevas AD; Chang AL; Divi V
    Head Neck; 2017 May; 39(5):881-885. PubMed ID: 28252823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment evaluation of metastatic lymph nodes after concurrent chemoradiotherapy in patients with head and neck squamous cell carcinoma.
    Nishimura G; Matsuda H; Taguchi T; Takahashi M; Komatsu M; Sano D; Sakuma N; Arai Y; Takahashi H
    Anticancer Res; 2012 Feb; 32(2):595-600. PubMed ID: 22287750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography After Concurrent Chemoradiotherapy in Locally Advanced Head-and-Neck Squamous Cell Cancer: The ECLYPS Study.
    Van den Wyngaert T; Helsen N; Carp L; Hakim S; Martens MJ; Hutsebaut I; Debruyne PR; Maes ALM; van Dinther J; Van Laer CG; Hoekstra OS; De Bree R; Meersschout SAE; Lenssen O; Vermorken JB; Van den Weyngaert D; Stroobants S;
    J Clin Oncol; 2017 Oct; 35(30):3458-3464. PubMed ID: 28854069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microscopic Extranodal Extension in HPV-Negative Head and Neck Cancer and the Role of Adjuvant Chemoradiation.
    Yan F; Li H; de Almeida JR; Kaczmar JM; Pipkorn P; Zenga J; Richardson MS; Neskey DM; Sharma AK; Day TA; Graboyes EM
    Otolaryngol Head Neck Surg; 2021 Oct; 165(4):536-549. PubMed ID: 33618570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological assessment of cervical lymph node identifies patients with head and neck squamous cell carcinoma (HNSCC): who would benefit from chemoradiation after surgery?
    Wan XC; Egloff AM; Johnson J
    Laryngoscope; 2012 Dec; 122(12):2712-22. PubMed ID: 23060119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.